{"id":74991,"date":"2023-03-03T15:29:38","date_gmt":"2023-03-03T13:29:38","guid":{"rendered":"https:\/\/forklog.com\/en\/?p=74991"},"modified":"2025-09-10T02:55:25","modified_gmt":"2025-09-09T23:55:25","slug":"media-neuralink-denied-permission-to-test-brain-implants-in-humans","status":"publish","type":"post","link":"https:\/\/forklog.com\/en\/media-neuralink-denied-permission-to-test-brain-implants-in-humans\/","title":{"rendered":"Media: Neuralink denied permission to test brain implants in humans"},"content":{"rendered":"<p>American regulators declined to grant Neuralink permission to test brain implants in humans. <a href=\"https:\/\/www.reuters.com\/investigates\/special-report\/neuralink-musk-fda\/\" target=\"_blank\" rel=\"noopener nofollow\" title=\"\">Reuters<\/a> reports.<\/p>\n<p>According to the agency, in early 2022, Elon Musk&#8217;s startup filed an application with the U.S. Food and Drug Administration (FDA). However, the agency judged the current risks too high.<\/p>\n<p>In its rationale for the denial, the FDA enumerated dozens of issues that could arise during the trials. The greatest concerns were:<\/p>\n<ul class=\"wp-block-list\">\n<li>the implant&#8217;s lithium battery;<\/li>\n<li>the risk of tiny wires migrating to other parts of the brain;<\/li>\n<li>the possibility of removing the device without damaging brain tissue.<\/li>\n<\/ul>\n<p>Former and current Neuralink employees told the agency that a year after the denial the company had not solved the challenges. Nevertheless, Musk <a href=\"https:\/\/forklog.com\/en\/news\/neuralink-to-test-brain-computer-interface-on-humans-within-six-months\">promised<\/a> that in spring 2023 the company would obtain the necessary approvals.<\/p>\n<p>Neuralink&#8217;s official representatives did not respond to media inquiries. The FDA declined to comment, citing laws protecting commercial information.<\/p>\n<p>Neuralink was founded in 2016. The company is developing neural implants that, according to Musk, could help treat conditions such as paralysis and blindness.<\/p>\n<p>In April 2021, the billionaire demonstrated a monkey with an implanted chip in the brain cortex playing ping-pong by thought alone.<\/p>\n<p><script async src=\"https:\/\/telegram.org\/js\/telegram-widget.js?21\" data-telegram-post=\"forklogAI\/51\" data-width=\"100%\"><\/script><\/p>\n<p>However, in 2022 the company faced a wave of criticism. Animal rights activists <a href=\"https:\/\/forklog.com\/en\/news\/elon-musks-neuralink-accused-of-cruel-treatment-of-animals\">accused Neuralink<\/a> of causing &#8220;great suffering&#8221; to the test monkeys. Later Reuters reported that the United States Department of Agriculture&#8217;s Inspector General <a href=\"https:\/\/forklog.com\/en\/news\/media-u-s-authorities-probe-neuralinks-animal-testing\">launched an investigation<\/a> into the matter.<\/p>\n<p>Earlier, Neuralink opened a vacancy for the director of clinical trials.<\/p>\n<p>In November, Science, the publication owned by Neuralink co-founder Max Hodak, <a href=\"https:\/\/forklog.com\/en\/news\/neuralink-rival-develops-neural-implant-to-treat-blindness\">presented a neural interface<\/a> for treating blindness.<\/p>\n<p>Earlier, the American startup Synchron <a href=\"https:\/\/forklog.com\/en\/news\/in-the-united-states-testing-has-begun-for-the-first-commercial-neural-interface\">launched clinical trials<\/a> of the first commercial brain implant.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>American regulators declined to grant Neuralink permission to test brain implants in humans.<\/p>\n","protected":false},"author":1,"featured_media":74992,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"select":"1","news_style_id":"1","cryptorium_level":"","_short_excerpt_text":"","creation_source":"","_metatest_mainpost_news_update":false,"footnotes":""},"categories":[3],"tags":[438,1341,26],"class_list":["post-74991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-analysis","tag-artificial-intelligence","tag-neuralink","tag-usa"],"aioseo_notices":[],"amp_enabled":true,"views":"22","promo_type":"1","layout_type":"1","short_excerpt":"","is_update":"","_links":{"self":[{"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/posts\/74991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/comments?post=74991"}],"version-history":[{"count":1,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/posts\/74991\/revisions"}],"predecessor-version":[{"id":74993,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/posts\/74991\/revisions\/74993"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/media\/74992"}],"wp:attachment":[{"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/media?parent=74991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/categories?post=74991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/tags?post=74991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}